| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 08/19/2009 | CN100528875C Crystal-free type Idi prone and its preparing method |
| 08/19/2009 | CN100528874C Pyrrolo [2,3d] pyrimidine compositions and their use |
| 08/19/2009 | CN100528873C 3 position substituted mesoazalene compounds and high efficiency synthesis method |
| 08/19/2009 | CN100528350C Method for increasing the cutting hardness of a molded body |
| 08/19/2009 | CN100528162C Pharmaceutical compositions |
| 08/19/2009 | CN100528154C Malonyl-COA decarboxylase inhibitors useful as metabolic modulators |
| 08/18/2009 | US7576245 Using a fluorinated phenyl compound containing electrophilic and nucleophilic groups; increasing the fluorous nature of an organic compound; 4-(1H,1H,2H,2H-Perfluorodecyl)benzenesulfonamide; N-[4-(1H,1H,2H,2H-perfluorodecyl)benzyloxycarbonyloxy]succinimide |
| 08/18/2009 | US7576199 Near infrared dyes |
| 08/18/2009 | US7576092 Benzofuro- and benzothienopyrimidine modulators of the histamine H4 receptor |
| 08/18/2009 | US7576091 Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting protein kinases |
| 08/18/2009 | US7576090 Benzazole analogues and uses thereof |
| 08/18/2009 | US7576087 3-(Phenylsulfonyl)-7-piperazin-1-yl-1H-pyrazolo[4,3-b]pyridine; 5-HT receptor subtype 5HT6; selective serotonin receptor antagonist; cognition actiators; alzheimer's disease; attention deficit disorder; antidepressant; antiepileptic agent; anxiolytic agents; obsessive compulsive disorder; Parkinson's |
| 08/18/2009 | US7576085 Imidazo[1,2-a]pyrazine compounds; cancers |
| 08/18/2009 | US7576084 1-(Phenylmethylaminocarbonyl-),4,7-di(oxo-),6-(4-(hydroxylphenyl),8-(piperidino(1,3-phenylene)methyl)-perhydro(pyrazino(2,1-c)-as-triazine); disorders modulated by Wnt-signaling pathway; anticarcinogenic agents; colorectal cancer; restenosis; polycystic kidney disease; angiogenesis inhibition |
| 08/18/2009 | US7576082 rac-6-Chloro-3-(3-chloro-benzyl)-3-(1-methyl-1H-pyrazol-4-yl)-1,3-dihydro-indol-2-one; murine double minute (MDM2 ) oncogene inhibitor; feedback control loop of p53 mutant cells; inhibit the interaction between p53 and MDM2 proteins |
| 08/18/2009 | US7576077 9-{[5-(3-Chlorophenyl)-1,2,4-oxadiazol-3-yl]methyl}-3-pyridin-4-yl-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a][1,3]diazepine; Group 1 receptor subtype; analgesics; psychological disorders; gastroesophageal reflux; neuroprotectans; antiischemic agents; hyperglycemic agents; neurodegenerative disease |
| 08/18/2009 | US7576074 Receptor-type kinase modulators and methods of use |
| 08/18/2009 | US7576072 Heterocyclic inhibitors of MEK and methods of use thereof |
| 08/18/2009 | CA2585557C Pyrazolo[4,3-d] pyrimidine derivatives useful as pde-5 inhibitors |
| 08/18/2009 | CA2429133C Novel imidazole derivatives, production method thereof and use thereof |
| 08/18/2009 | CA2400268C Pyrrolopyrimidinone derivatives, process of preparation and use |
| 08/18/2009 | CA2392030C Urea compounds having muscarinic receptor antagonist activity |
| 08/18/2009 | CA2392028C Carbamate derivatives having muscarinic receptor antagonist activity |
| 08/13/2009 | WO2009100431A1 Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings |
| 08/13/2009 | WO2009100375A1 Substituted imidazopyridazines useful as kinase inhibitors |
| 08/13/2009 | WO2009100120A2 Pyridinyl-substituted piperazinyl oxoethyl tetrahydropyrazolopyridines |
| 08/13/2009 | WO2009099982A1 2-aminopyridine kinase inhibitors |
| 08/13/2009 | WO2009099929A1 Mesoionic pesticides |
| 08/13/2009 | WO2009099596A2 Macrocyclic serine protease inhibitors |
| 08/13/2009 | WO2009099163A1 Pyrrolopyrimidin derivative for use as pi3k inhibitor, and use thereof |
| 08/13/2009 | WO2009098257A1 Composition for dyeing keratin fibres comprising at least one cationic diamino-n,n-dihydropyrazolone derivative |
| 08/13/2009 | WO2009098236A1 Pyrrolo [2, 3-d] pyridines and use thereof as tyrosine kinase inhibitors |
| 08/13/2009 | WO2009097971A1 Triazolium salts as par1 inhibitors, production thereof, and use as medicaments |
| 08/13/2009 | WO2009097970A1 Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments |
| 08/13/2009 | WO2009097709A1 Pyrazolopyrimidinone-containing phenyl guanidine derivatives, pharmaceutical compositions containing them, process for their preparation and their use |
| 08/13/2009 | WO2009097695A1 Arylmethylidene heterocycles as novel analgesics |
| 08/13/2009 | WO2009074575A3 Organic compounds |
| 08/13/2009 | WO2009032754A3 Heterocyclodiazepine cannabinoid receptor modulators for treatment of disease |
| 08/13/2009 | WO2005122682A3 Process for the preparation of esters of piperazic acid |
| 08/13/2009 | US20090203901 Process for preparing pyrazole functionalized benzodiazepinones |
| 08/13/2009 | US20090203757 Ethylene glycol esters as photoactive agents |
| 08/13/2009 | US20090203719 Enhancing treatment of mdr cancer with adenosine a3 antagonists |
| 08/13/2009 | US20090203717 Fused heterocyclic compound |
| 08/13/2009 | US20090203702 INHIBITORS OF p38 |
| 08/13/2009 | US20090203672 Substituted Sulfonamide Compounds |
| 08/13/2009 | US20090203665 Heterocyclic-substituted phenyl methanones |
| 08/13/2009 | US20090203664 (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6- diazabicyclo[3.2.0]heptane |
| 08/13/2009 | US20090203577 Azepinoindole Derivatives As Pharmaceutical Agents |
| 08/13/2009 | US20090202480 Macrocyclic serine protease inhibitors |
| 08/13/2009 | US20090202478 inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV); useful in establishing or determining the binding site of other antiviral compounds, for example, by competitive inhibition; used to treat or prevent viral contamination of materials |
| 08/13/2009 | CA2714966A1 Arylmethylidene heterocycles as novel analgesics |
| 08/13/2009 | CA2714226A1 Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings |
| 08/13/2009 | CA2714177A1 Pyrrolo [2,3-d] pyridines and use thereof as tyrosine kinase inhibitors |
| 08/13/2009 | CA2713551A1 Triazolium salts as par1 inhibitors, production thereof, and use as medicaments |
| 08/13/2009 | CA2713550A1 Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments |
| 08/13/2009 | CA2713347A1 Mesoionic pesticides |
| 08/13/2009 | CA2712971A1 Macrocyclic serine protease inhibitors |
| 08/13/2009 | CA2711778A1 Pyrrolopyrimidine derivative as pi3k inhibitor and use thereof |
| 08/13/2009 | CA2711777A1 Novel pyrazolo [3,4-d] pyrimidine derivatives as anti-cancer drugs |
| 08/12/2009 | EP2088150A1 Fused pyrrolocarbazoles and methods for the preparation thereof |
| 08/12/2009 | EP2086981A1 Compounds for inhibiting mitotic progression |
| 08/12/2009 | EP2086980A1 Macrocyclic peptides as hepatitis c virus inhibitors |
| 08/12/2009 | EP2086979A2 Imidazoý1,2-b¨pyridazine and pyrazoloý1,5-a¨pyrimidine derivatives and their use as protein kinase inhibitors |
| 08/12/2009 | EP2086978A1 Amorphous form of n-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo [1,5-a]pyrimidin-7-yl]-phenyl-n-methyl-acetamide |
| 08/12/2009 | EP2086967A2 Inhibitors of hepatitis c virus |
| 08/12/2009 | EP1904461B1 Cyclic anilino-pyridinotriazines as gsk-3 inhibitors |
| 08/12/2009 | EP1392328B1 Medicament for protection in radiotherapy |
| 08/12/2009 | CN101506216A Fused imidazole derivatives for the treatment of disorders mediated by aldosterone synthase and/or 11-beta-hydroxylase and/or aromatase |
| 08/12/2009 | CN101506215A Adenosine A2a receptor antagonists |
| 08/12/2009 | CN101506214A Pyrazoloquinazolinones as PARP inhibitors |
| 08/12/2009 | CN101506213A Amino- imidazolones and their use as a medicament for treating cognitive impairment. alzheimer disease, neurodegeneration and dementia. |
| 08/12/2009 | CN101506212A Amino- imidazolones and their use as a medicament for treating cognitive impairment. alzheimer disease, neurodegeneration and dementia. |
| 08/12/2009 | CN101506211A 激酶拮抗剂 Kinase antagonists |
| 08/12/2009 | CN101505752A Prolyl hydroxylase inhibitors |
| 08/12/2009 | CN100526316C Triazole miazines derivative |
| 08/11/2009 | US7572914 2-hydroxy-1H-indol derivatives enzyme inhibitors for preventing or treating inflammation, inflammatory bowel disease, psoriasis, dementia related diseases Alzheimer's Disease, Cognitive Impairment, arthritis, neurodegenerative diseases, amyotrophic lateral sclerosis, Down syndrome, Huntington's Disease |
| 08/11/2009 | US7572817 Carboxypeptidase U inhibitors; thrombosis, atherosclerosis, adhesions, dermal scarring, cancer, fibrotic conditions, inflammatory diseases; e.g. 2-[(6-Aminopyridin-3-yl)methyl]-3-mercapto-5-[3-(pyrrolidin-1-ylcarbonyl)phenyl]pentanoic acid |
| 08/11/2009 | US7572816 Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders |
| 08/11/2009 | US7572806 PPAR active compounds |
| 08/11/2009 | US7572802 For central nervous system diseases, in particular Parkinson's disease, Extra Pyramidal Syndrome, restless legs syndrome and attention deficit hyperactivity disorder |
| 08/11/2009 | US7572799 Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors |
| 08/11/2009 | US7572795 Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors |
| 08/11/2009 | US7572787 Substituted naphthalene sulfonamides |
| 08/11/2009 | US7572784 Inhibit Aurora kinase; cancer; 4-[9-Chloro-7-(2-fluoro-phenyl)-5H-benzo[c]pyrimido[4,5-e]azepin-2-ylamino]-N-(2-methylamino-ethyl)-benzamide; 9-Chloro-N-(4-{[3-(dimethylamino)azetidin-1-yl]carbonyl}phenyl)-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-amine |
| 08/11/2009 | CA2482551C 1-(4-piperidinyl) benzimidazolones as histamine h3 antagonists |
| 08/11/2009 | CA2433874C Improved process for carbapenem synthesis |
| 08/11/2009 | CA2417590C Prophylactic or ameliorative agent for insulin resistance and/or obesity |
| 08/11/2009 | CA2359772C Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 08/11/2009 | CA2222552C N-oxides as antibacterial agents |
| 08/06/2009 | WO2009097578A1 Oxim derivatives as hsp90 inhibitors |
| 08/06/2009 | WO2009097515A2 [a]-fused indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| 08/06/2009 | WO2009097490A1 1H-PYRAZOLO[3,4-D]PYRIMIDINE, PURINE, 7H-PURIN-8(9H)-ONE, 3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE, AND THIENO[3,2-D]PYRIMIDINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES |
| 08/06/2009 | WO2009097446A1 Pyrazolopyrimidine pi3k inhibitor compounds and methods of use |
| 08/06/2009 | WO2009097405A2 Compounds and methods for preparing diazaspiro derivatives |
| 08/06/2009 | WO2009097233A1 Imidazopyrazines as protein kinase inhibitors |
| 08/06/2009 | WO2009096445A1 Nerve trunk cell propagation accelerator |
| 08/06/2009 | WO2009096435A1 Condensed heterocyclic derivatives and uses thereof |
| 08/06/2009 | WO2009095923A2 Corroles for neuroprotection and neurorescue |
| 08/06/2009 | WO2009095789A1 Substituted arylamide diazepinopyrimidone derivatives for the treatment of neurodegenerative diseases caused by abnormal activity of gsk3-beta |
| 08/06/2009 | WO2009095282A2 Photolatent amidine bases for redox curing of radically curable formulations |